Treatment for Obesity

Phase-Based Estimates
Penn State College of Medicine, Hershey, PA
+3 More
< 65
Eligible conditions

Study Summary

Prevention of Obesity in Infants of Overweight and Obese Women

See full description

Eligible Conditions

  • Obesity
  • Pediatric Obesity
  • Overweight
  • Obesity, Infant

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome in patients with Obesity. Measurement will happen over the course of 6 months.

6 months
Infant normalized weight at 6 months of age

Trial Safety

Safety Estimate

1 of 3

Trial Design

1 Treatment Groups


This trial requires 240 total participants across 1 different treatment groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 6 months for reporting.

Who is running the study

Principal Investigator
M. R.
Prof. Michael Ross, Distinguished Professor of Obstetrics & Gynecology
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Closest Location

Penn State College of Medicine - Hershey, PA

Eligibility Criteria

This trial is for female patients aged 65 and younger. There are 2 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Breast Milk Calibration Study: Study women (pre-pregnant BMI 25-29.9 and ≥30) who are providing exclusive human milk via pumping and bottle (50%/50% male/female) will be recruited at the 3-6 week postpartum visit.
Formula Milk Calibration Study: Study women (pre-pregnant BMI 25-29.9 and ≥30) who are providing formula via bottle (50%/50% male/female) will be recruited at the 3-6 week postpartum visit.

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Obesity by sharing your contact details with the study coordinator.